-
-
Call more information
660-596-2224 -
ASA Monitor December 2023, Vol. 87, 18. Small molecule drug for gene therapies Researchers at the Children’s Hospital of Philadelphia have discovered that a readily available and inexpensive small-molecule drug can enhance the fitness of hematopoietic stem and progenitor cells (HSPCs) when they are modified outside the body, potentially improving the success of procedures like ex […]
Read MoreAuthor: Keith H. Baker, M.D., Ph.D. Anesthesiology Newly Published on November 2023. To the Editor: It was a pleasure to see a letter to the editor in Anesthesiology that mentioned the learning advantage of pictures compared to words.1 This advantage is known as the picture superiority effect. I was skeptical of the stated learning advantage of the picture […]
Read MoreAuthor: George Williams, MD, FASA, FCCM, FCCP ASA Monitor December 2023, Vol. 87, 26. Diversity education and awareness have long been recognized by many organizations outside and inside the house of medicine as being important for achieving resilient organizations. With regard to medical education, the Association of American Medical Colleges famously announced an ambitious goal of […]
Read MoreAuthor: Keya A. Locke, MD, MBA ASA Monitor December 2023, Vol. 87, 19. As we take stock of where we are and all that has come before – of all that was lost and all that was won on the arduous road toward equity in the realization of the American dream for all peoples, I am compelled to […]
Read MoreAUTHORS: Thilen, Stephan R. MD, MS et al Anesthesia & Analgesia 136(6):p 1143-1153, June 2023. BACKGROUND: Postoperative residual neuromuscular blockade (PRNB) is defined as an adductor pollicis train-of-four ratio (TOFR) <0.9. It is a common postoperative complication when nondepolarizing muscle relaxants are either not reversed or reversed with neostigmine. PRNB has been reported in 25% to […]
Read More